ARKG ETF
ARK Genomic Revolution ETF by ARK
GenomicsBiotechInnovationThematic ETF
$46.70
-2.54(-5.16%)
Latest available quote
AUM
$2.2B
Expense Ratio
0.75%
Dividend Yield
-
YTD Return
+60.04%
NAV
$46.64
Tracking Index
Actively Manage…
Volume
9.8M
Risk Level
High
ARK Genomic Revolution ETF (ARKG) ETF Overview
ARK Genomic Revolution ETF (ARKG) is an ETF managed by ARK with an AUM of $2.22B and an expense ratio of 0.75%. Get the live price, chart, holdings, performance, dividends, risk and more in one place.
ARKG Price Chart
Trend:Momentum:Volatility:Volume:
The fastest way to follow markets
Launch ChartETF Overview
The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity securities issued by both domestic and international companies. These companies are strategically chosen from various sectors based on their direct connection to the fund's core investment principle: the groundbreaking genomics revolution.
Fund ProviderARK
Fund Inception2014-10-31
Legal StructureOpen Ended
Expense Ratio0.75%
BenchmarkActively Managed
Replication MethodFull Replication
Top 30 Holdings
| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 |  10X GENOMICS INC-CLASS A | TXG | 8.74% |
| 2 |  TEMPUS AI INC-CL A | TEM | 8.62% |
| 3 |  TWIST BIOSCIENCE CORP | TWST | 8.22% |
| 4 |  CRISPR THERAPEUTICS AG | CRSP | 5.59% |
| 5 |  NATERA INC | NTRA | 4.93% |
| 6 |  GUARDANT HEALTH INC | GH | 4.93% |
| 7 |  ILLUMINA INC | ILMN | 4.89% |
| 8 |  ABSCI CORP | ABSI | 4.64% |
| 9 |  ELI LILLY & CO | LLY | 4.01% |
| 10 |  CAREDX INC | CDNA | 3.86% |
| 11 |  BEAM THERAPEUTICS INC | BEAM | 3.45% |
| 12 |  VERACYTE INC | VCYT | 3.40% |
| 13 |  RECURSION PHARMACEUTICALS-A | RXRX | 3.13% |
| 14 |  SCHRODINGER INC | SDGR | 2.82% |
| 15 |  COMPASS PATHWAYS PLC | CMPS | 2.80% |
| 16 |  NURIX THERAPEUTICS INC | NRIX | 2.77% |
| 17 |  ADAPTIVE BIOTECHNOLOGIES | ADPT | 2.30% |
| 18 |  PERSONALIS INC | PSNL | 2.03% |
| 19 |  BUTTERFLY NETWORK INC | BFLY | 1.90% |
| 20 |  IONIS PHARMACEUTICALS INC | IONS | 1.90% |
| 21 |  GENEDX HOLDINGS CORP | WGS | 1.78% |
| 22 |  ARCTURUS THERAPEUTICS HOLDIN | ARCT | 1.57% |
| 23 |  ALAMAR BIOSCIENCES INC | ALMR | 1.51% |
| 24 |  PRIME MEDICINE INC | PRME | 1.38% |
| 25 |  908 DEVICES INC | MASS | 1.15% |
| 26 |  PACIFIC BIOSCIENCES OF CALIF | PACB | 1.06% |
| 27 |  GENERATE BIOMEDICINES INC | GENB | 1.01% |
| 28 |  SCRIBE THERAPEUTICS INC | SCTX | 0.89% |
| 29 |  INTELLIA THERAPEUTICS INC | NTLA | 0.87% |
| 30 |  CERUS CORP | CERS | 0.86% |
Sector Exposure
Healthcare
96.0%
Technology
3.4%
Cash & Others
0.7%
Performance Overview
YTD Return
+60.04%
1Y Return
+108.07%
3Y Return
+150.10%
5Y Return
+192.13%
10Y Return
+306.21%
Similar ETFs
ETF Flow Signals
Net Flows (1D)
+$1.21B
Net Flows (5D)
+$5.67B
Net Flows (YTD)
+$68.4B
Net SellingNet Buying
Top Buyers (1D)
Institutions, Pension Funds
Top Sellers (1D)
Retail, Hedge Funds
Risk Watch
Beta (3Y)
1.00
Std Dev (3Y)
14.5%
Sharpe Ratio (3Y)
0.72
Concentration RiskModerate
Rate SensitivityElevated
Leverage CautionLow
Income Ideas
| Ticker | Div Yield | Freq | Next Ex-Date |
|---|---|---|---|
| SPY | 1.3% | Quarterly | Jun 21 |
| SCHD | 3.53% | Quarterly | Jun 26 |
| VYM | 2.89% | Quarterly | Jun 20 |
Market data provided by third parties and may be delayed. Not investment advice. Past performance is not indicative of future results.